Skip to main navigation Skip to search Skip to main content

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

Translated title of the contribution: Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.
  • A. Benard
  • , A.I. van Sighem
  • , A. Taieb
  • , E. Valadas
  • , J.-L. Ruelle
  • , V. Soriano
  • , A. Calmy
  • , C. Balotta
  • , F. Damond
  • , F. Brun-Vezinet
  • , G. Chene
  • , I.M. Hoepelman
  • , S.P.M. Geelen
  • , X et al.
  • , S. Matheron

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionImmunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.
Original languageUndefined/Unknown
Pages (from-to)1257-1266
Number of pages10
JournalClinical Infectious Diseases
Volume52
Issue number10
Publication statusPublished - 2011

Cite this